FABP4 and fatty liver disease: Fatty liver was assessed by FLI which is a subrogated of imaging techniques (Cuthbertson et al., 2014); however, further validation by imaging techniques and/or liver biopsy is warranted before to fully consider serum FABP4 as a realistic option for liver steatosis determination.